Sun Pharma Advanced Research's Q3 net loss widens to Rs 41 cr

Sun Pharma Advanced Research Company (SPARC) today reported a widening of its net loss to Rs 41.02 crore for the quarter ended December 31, mainly on rise in expenses.
The company had posted a net loss of Rs 18.91 crore for the corresponding period of the previous fiscal, SPARC said in a BSE filing.
Total income from operations of the company however rose to Rs 33.55 crore for the quarter under review as against Rs 31.28 crore for the same period a year ago.
Shares of Sun Pharma Advanced Research Company closed at Rs 286.20 per scrip on the BSE, down 3.33 per cent.